“Effects of Galcanezumab on Acute Medication Use and Health Care Resource Utilization in Treatment-Resistant Migraine: Results from Randomized, Double Blind, Placebo-Controlled Clinical Trial, Conquer”. Headache Medicine, vol. 11, no. Supplement, Nov. 2020, p. 27, https://doi.org/10.48208/HeadacheMed.2020.Supplement.27.